# Pantelis Sarafidis

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/pantelis-sarafidis/

## Facts

| Field | Value |
| --- | --- |
| Citations | 19,709 |
| Field | Blood Pressure and Hypertension Studies |
| h-index | 68 |
| i10-index | 284 |
| Last Known Institution | Aristotle University of Thessaloniki |
| OpenAlex ID | https://openalex.org/A5028159985 |
| ORCID iD | https://orcid.org/0000-0002-9174-4018 |
| Works | 698 |

## Researcher papers

- [2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension](https://scholariq.org/papers/2023-esh-guidelines-for-the-management-of-arterial-hypertension-the-task-force/)
- [The systemic nature of CKD](https://scholariq.org/papers/the-systemic-nature-of-ckd/)
- [Cardiovascular complications in chronic kidney disease: a review from the European Renal and Cardiovascular Medicine Working Group of the European Renal Association](https://scholariq.org/papers/cardiovascular-complications-in-chronic-kidney-disease-a-review-from-the/)
- [Lipid management in patients with chronic kidney disease](https://scholariq.org/papers/lipid-management-in-patients-with-chronic-kidney-disease/)
- [Blood pressure and volume management in dialysis: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference](https://scholariq.org/papers/blood-pressure-and-volume-management-in-dialysis-conclusions-from-a-kidney/)
- [Hypertension in dialysis patients: a consensus document by the European Renal and Cardiovascular Medicine (EURECA-m) working group of the European Renal Association–European Dialysis and Transplant Association (ERA-EDTA) and the Hypertension and the Kidney working group of the European Society of Hypertension (ESH)*](https://scholariq.org/papers/hypertension-in-dialysis-patients-a-consensus-document-by-the-european-renal-and/)
- [SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA](https://scholariq.org/papers/sglt-2-inhibitors-and-glp-1-receptor-agonists-for-nephroprotection-and/)
- [Effect of Thiazolidinediones on Albuminuria and Proteinuria in Diabetes: A Meta-analysis](https://scholariq.org/papers/effect-of-thiazolidinediones-on-albuminuria-and-proteinuria-in-diabetes-a-meta/)
- [Prevalence and Factors Associated with Hyperkalemia in Predialysis Patients Followed in a Low-Clearance Clinic](https://scholariq.org/papers/prevalence-and-factors-associated-with-hyperkalemia-in-predialysis-patients/)
- [Design and baseline characteristics of the Finerenone, in addition to standard of care, on the progression of kidney disease in patients with Non-Diabetic Chronic Kidney Disease (FIND-CKD) randomized trial](https://scholariq.org/papers/design-and-baseline-characteristics-of-the-finerenone-in-addition-to-standard-of/)

## Researcher topics

- [Blood Pressure and Hypertension Studies](https://scholariq.org/topics/blood-pressure-and-hypertension-studies/)
- [Dialysis and Renal Disease Management](https://scholariq.org/topics/dialysis-and-renal-disease-management/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Cardiovascular Health and Disease Prevention](https://scholariq.org/topics/cardiovascular-health-and-disease-prevention/)
- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

## Researcher university

- [Aristotle University of Thessaloniki](https://scholariq.org/institutions/aristotle-university-of-thessaloniki/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.